In contrast, routine surveillance of SPINK1 in post-treatment individuals through a noninvasive route such as liquid biopsy provides a novel, handy, and precise strategy for both prognosis and prevention of advanced pathologies in future cancer medicine. This evidence concerns the gene SPINK1 and cancer.